Stockreport

Annovis Awarded $1.7 Million NIH Grant for ANVS401 Chronic Toxicology Studies

Annovis Bio, Inc.  (ANVS) 
PDF BERWYN, Pa., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s (AD) , Parkinson’s [Read more]